Philips Thailand
Philips Thailand is the Thai subsidiary of Koninklijke Philips NV (AMS: PHIA). ~8% of Thai medical-device market value. Portfolio: imaging (CT, MRI, ultrasound, interventional X-ray), patient monitoring (IntelliVue), sleep, respiratory (post-2021 CPAP recall affected brand). Long operating history in Thailand (since 1952 consumer, medical-device combined presence). Healthcare-only focus post Philips strategic-review.
Snapshot
Headline numbers a buyer checks first.
Thai market share
~8% by value
FY2024
Parent
Koninklijke Philips NV (AMS: PHIA)
Subsidiary since 1952
Portfolio
Imaging, monitoring, respiratory
FY2024
Status
Private Thai subsidiary
Ongoing
What this subsidiary actually does
Philips Thailand imports, installs imaging, monitoring, respiratory equipment. Imaging: CT, MRI, ultrasound (EPIQ, Affiniti), interventional X-ray (Azurion). Patient monitoring: IntelliVue platform deployed widely in Thai ICU, operating-room settings. Sleep, respiratory: formerly strong but post-2021 global CPAP recall (Respironics) remains a reputational overhang, continues regulatory attention.[]
Competitive position: #3-tier imaging vendor in Thailand; leader in some patient-monitoring categories. Post-CPAP-recall the brand needs to rebuild; strategic focus on core diagnostic, image-guided therapy, monitoring after Philips divested consumer, lighting businesses.[]
Business segments
Imaging
CT, MRI, ultrasound, interventional X-ray
Philips EPIQ, Affiniti ultrasound; Azurion interventional X-ray; CT and MRI installed across Thai private hospitals. Imaging accounts for an estimated 55–60% of Thai healthcare revenue.
Patient monitoring
IntelliVue platform — ICUs and ORs
IntelliVue patient-monitoring systems are widely deployed in Thai ICU and operating-room settings. Monitoring is estimated to contribute 20–25% of Thai revenues, with recurring service contracts.
Sleep and respiratory
Post-recall CPAP recovery
Respironics CPAP recall (2021) affected 5.5M global devices. Thai recall volumes were smaller but reputational damage persists. Philips exited the sleep-and-respiratory business in 2024, divesting Respironics.
Services and digital
Performance Bridge remote monitoring
Philips HealthSuite digital platform and service contracts (MTBF-linked) provide recurring revenue. Thai hospital capex increasingly includes multi-year managed-service agreements.
Thai medical imaging market — peer comparison
Estimated Thai medical imaging market share by value and product focus (FY2024).
Canon Medical Thailand
Parent / ticker
Canon (TYO)
Est. Thai share
~5%
Strongest category
CT, MRI mid-tier
Mindray Thailand
Parent / ticker
Mindray (SZSE)
Est. Thai share
~6%
Strongest category
Ultrasound, monitoring (value tier)
| Vendor | Parent / ticker | Est. Thai share | Strongest category |
|---|---|---|---|
| Siemens Healthineers Thailand | SHL (ETR) | ~10% | CT, MRI, IVD automation |
| GE HealthCare Thailand | GEHC (NASDAQ) | ~12% | Ultrasound, MRI, monitoring |
| Philips Thailand | PHIA (AMS) | ~8% | Interventional X-ray, monitoring |
| Canon Medical Thailand | Canon (TYO) | ~5% | CT, MRI mid-tier |
| Mindray Thailand | Mindray (SZSE) | ~6% | Ultrasound, monitoring (value tier) |
Watchpoints 2025–2026
CPAP recall legacy
Respironics liability and brand rebuild
Philips settled Respironics recall liability in the US for USD 1.1B (2024). Thai market brand damage in sleep/respiratory requires active remediation; Thai FDA may require local market update.
IntelliVue monitoring
ICU expansion in Thai private hospitals
BDMS, Bumrungrad, and Bangkok Dusit are expanding ICU capacity. IntelliVue refresh cycles (typically 7–10 years) determine near-term monitoring revenue.
Imaging vs Mindray
Value-tier competition intensifying
Mindray and other Chinese vendors are winning price-sensitive Thai public hospital tenders. Philips must defend mid-tier ultrasound position with TCO (total cost of ownership) arguments.
Related Market profiles
Peers, parents, partners, agencies, and other Medical Devices actors.
Competitor
Siemens Healthineers Thailand
Direct imaging competitor.
Open Market profile →
Competitor
GE HealthCare Thailand
Direct imaging, monitoring competitor.
Open Market profile →
Sector peer
Abbott Thailand
US-parent MNC diagnostics, CGM, nutrition, cardiovascular; FreeStyle Libre anchor; ~6% Thai medical-device market share.
Open Market profile →
Sector peer
Becton Dickinson Thailand (BD Thailand)
Thai subsidiary of Becton Dickinson (NYSE: BDX); distributes and markets BD's medical devices, diagnostics, and life-science products across the Thai healthcare market.
Open Market profile →
Sources + data provenance
Every filing, filing-adjacent register, or trusted industry source cited in this profile.
Philips Thailand — Subsidiary Disclosures
| Source | Publisher | Grade | As of |
|---|---|---|---|
| Philips Thailand — Subsidiary Disclosures | Philips Thailand | Supporting | 2025-12-31 |